2024-09-16 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
MYGN |
Sell
All
|
2.3% |
Assets Rebalanced
None
2024-09-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.32% |
-2.15% |
2024-09-09 |
The percentage of cash held in the portfolio is:
90.68%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVCR |
Sell
All
|
-3.99% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
9.12% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.55% |
0.26% |
2024-09-09 |
The percentage of cash held in the portfolio is:
81.33%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
TVTX |
Sell
All
|
33.75% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
13.14% |
33.96% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.97% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.6% |
0.63% |
2024-09-09 |
The percentage of cash held in the portfolio is:
68.29%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.39% |
14.37% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.59% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.25% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
9.68% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
60.08%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MGNX |
Sell
All
|
-7.41% |
ESPR |
Sell
All
|
-9.84% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MGNX
MacroGenics, Inc.
|
Buy |
9.58% |
-3.7% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.35% |
-6.01% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.24% |
3.44% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.83% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.83% |
0% |
2024-09-06 |
The percentage of cash held in the portfolio is:
51.17%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MGNX
MacroGenics, Inc.
|
Buy |
9.36% |
-5.41% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.84% |
-0.55% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.31% |
4.69% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.78% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
60.7%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
3.96% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
10.17% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.02% |
-10.38% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.31% |
-6.55% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.97% |
0% |
2024-09-02 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.92% |
0% |
2024-09-04 |
The percentage of cash held in the portfolio is:
51.61%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-09-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NEOG
Neogen Corporation
|
Buy |
9.97% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.78% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.75% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
50.98%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
NA |
AADI |
Sell
All
|
NA |
Assets Rebalanced
None
2024-09-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Buy |
9.42% |
-5.04% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.26% |
3.43% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.97% |
0.35% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.78% |
-0.81% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.75% |
-1.15% |
2024-08-29 |
MGNX
MacroGenics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.76% |
0% |
2024-09-02 |
The percentage of cash held in the portfolio is:
31.29%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CERS
Cerus Corporation
|
Buy |
9.55% |
-3.78% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.92% |
0% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.89% |
-0.41% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.89% |
0.36% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.93% |
0.77% |
2024-08-29 |
The percentage of cash held in the portfolio is:
50.82%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
2.62% |
AGEN |
Sell
All
|
-8.78% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.37% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.33% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.39% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.58% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.77% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
9.91% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.91% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
31.74%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Sell
All
|
-3.45% |
APLS |
Sell
All
|
-4.2% |
ORGO |
Sell
All
|
3.53% |
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.55% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.16% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.24% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.07% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.53% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.38% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
9.78% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
21.57%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.51% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.6% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.28% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.36% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.3% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.59% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.59% |
0% |
2024-08-27 |
The percentage of cash held in the portfolio is:
30.77%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.4% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.72% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.61% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.9% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
51.48%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.8% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
70.6%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-07 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
5.19% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RMD
ResMed Inc.
|
Buy |
9.52% |
7.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
90.48%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
-1.96% |
HQY |
Sell
All
|
-11.82% |
SAVA |
Sell
All
|
95.11% |
SAGE |
Sell
All
|
-12.65% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
10.16% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.7% |
-3.16% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.8% |
17.76% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.85% |
-1.73% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.73% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
9.35% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
39.4%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
FATE |
Sell
All
|
-7.9% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.53% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.39% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.27% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
9.98% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.64% |
-1.69% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
11.85% |
20.78% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.65% |
-1.64% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.57% |
0% |
2024-07-30 |
The percentage of cash held in the portfolio is:
21.13%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.61% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.47% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
SAVA
Cassava Sciences, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
SAGE
Sage Therapeutics, Inc.
|
Buy |
9.85% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
21.69%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.54% |
-3.05% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.76% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.84% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
70.86%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.18% |
-7% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.87% |
0% |
2024-07-25 |
The percentage of cash held in the portfolio is:
80.95%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
9.8% |
0% |
2024-07-24 |
The percentage of cash held in the portfolio is:
90.2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VCYT |
Sell
All
|
-8.31% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
9.34% |
-5.34% |
2024-07-18 |
The percentage of cash held in the portfolio is:
90.66%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
WST |
Sell
All
|
-5.09% |
ANGO |
Sell
All
|
13.38% |
CYH |
Sell
All
|
1.62% |
TDOC |
Sell
All
|
-0.64% |
SGRY |
Sell
All
|
13.89% |
AVNS |
Sell
All
|
5.95% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
WST
West Pharmaceutical Services, Inc.
|
Buy |
8.94% |
-1.88% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
11% |
20.72% |
2024-07-12 |
CYH
Community Health Systems, Inc.
|
Buy |
9.67% |
6.2% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.75% |
7.04% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.54% |
15.66% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.74% |
6.89% |
2024-07-12 |
VCYT
Veracyte, Inc.
|
Buy |
9.59% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
30.77%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
PDSB |
Sell
All
|
13.92% |
ALT |
Sell
All
|
0.13% |
OPK |
Sell
All
|
7.58% |
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
10.58% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
10.07% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.85% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.96% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
ANGO
AngioDynamics, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
CYH
Community Health Systems, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
TDOC
Teladoc Health, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
SGRY
Surgery Partners, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
AVNS
Avanos Medical, Inc.
|
Buy |
9.59% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- WST
- ANGO
- CYH
- TDOC
- SGRY
- AVNS
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.8% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
9.8% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
9.8% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.8% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
60.8%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VERU |
Sell
All
|
-3.41% |
NVRO |
Sell
All
|
-2.79% |
VRDN |
Sell
All
|
-6.81% |
RYTM |
Sell
All
|
2.55% |
Assets Rebalanced
None
2024-07-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVRO
Nevro Corp.
|
Buy |
10.18% |
-2.67% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.7% |
-7.27% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
10% |
-4.36% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
10.82% |
3.41% |
2024-07-02 |
The percentage of cash held in the portfolio is:
59.3%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
NA |
Assets Rebalanced
None
2024-07-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
10.55% |
7.19% |
2024-06-28 |
NVRO
Nevro Corp.
|
Buy |
10.05% |
-3.02% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.54% |
-7.95% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
10.28% |
-0.77% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
11.19% |
7.95% |
2024-07-02 |
The percentage of cash held in the portfolio is:
48.38%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CHRS |
Sell
All
|
-19.65% |
STAA |
Sell
All
|
5.2% |
RARE |
Sell
All
|
2.79% |
ARDX |
Sell
All
|
-28.74% |
Assets Rebalanced
None
2024-07-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
STAA
STAAR Surgical Company
|
Buy |
10.77% |
12.05% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
9.92% |
3.19% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
9.72% |
3.75% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
9.56% |
2.16% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
8.71% |
-6.94% |
2024-07-01 |
NVRO
Nevro Corp.
|
Buy |
9.86% |
0% |
2024-07-02 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.86% |
0% |
2024-07-02 |
RYTM
Rhythm Pharmaceuticals, Inc.
|
Buy |
9.86% |
0% |
2024-07-02 |
VERU
Veru Inc.
|
Buy |
9.86% |
0% |
2024-07-02 |
The percentage of cash held in the portfolio is:
11.86%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ACAD |
Sell
All
|
1.01% |
MNKD |
Sell
All
|
-6.26% |
EGRX |
Sell
All
|
23.44% |
Assets Rebalanced
None
2024-07-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
9.72% |
2.33% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
9.14% |
-3.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
11.88% |
25% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
10.69% |
12.5% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
9.8% |
3.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
9.73% |
5% |
2024-06-28 |
ARDX
Ardelyx, Inc.
|
Buy |
9.26% |
0% |
2024-07-01 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
9.26% |
0% |
2024-07-01 |
The percentage of cash held in the portfolio is:
20.52%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
9.96% |
3.09% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
9.41% |
-2.58% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.82% |
12.05% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
10.68% |
10.52% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
10.04% |
3.94% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
9.42% |
0% |
2024-06-28 |
The percentage of cash held in the portfolio is:
39.67%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
9.56% |
-2.39% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
9.37% |
-4.42% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.76% |
9.82% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
10.54% |
7.54% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
9.97% |
1.71% |
2024-06-26 |
The percentage of cash held in the portfolio is:
49.8%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FGEN |
Sell
All
|
-12.08% |
Assets Rebalanced
None
2024-06-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
9.69% |
-1.76% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
9.51% |
-3.5% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
9.61% |
-2.5% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.01% |
1.56% |
2024-06-25 |
STAA
STAAR Surgical Company
|
Buy |
9.86% |
0% |
2024-06-26 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
9.86% |
0% |
2024-06-26 |
The percentage of cash held in the portfolio is:
41.45%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-06-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
9.8% |
0% |
2024-06-25 |
MNKD
MannKind Corporation
|
Buy |
9.8% |
0% |
2024-06-25 |
FGEN
FibroGen, Inc.
|
Buy |
9.8% |
0% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2024-06-25 |
The percentage of cash held in the portfolio is:
60.8%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-23 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PODD |
Sell
All
|
-2.32% |
Assets Rebalanced
None
2024-05-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PODD
Insulet Corporation
|
Buy |
8.95% |
-1.4% |
2024-05-17 |
The percentage of cash held in the portfolio is:
91.05%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BLFS |
Sell
All
|
-3.34% |
CYH |
Sell
All
|
-2.94% |
OMI |
Sell
All
|
-10.67% |
CUTR |
Sell
All
|
-7.69% |
Assets Rebalanced
None
2024-05-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
BLFS
BioLife Solutions, Inc.
|
Buy |
9.61% |
-2.67% |
2024-05-15 |
CYH
Community Health Systems, Inc.
|
Buy |
9.61% |
-2.67% |
2024-05-15 |
OMI
Owens & Minor, Inc.
|
Buy |
8.98% |
-9% |
2024-05-15 |
CUTR
Cutera, Inc.
|
Buy |
9.03% |
-8.5% |
2024-05-15 |
PODD
Insulet Corporation
|
Buy |
8.99% |
-0.67% |
2024-05-17 |
The percentage of cash held in the portfolio is:
53.78%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VCYT |
Sell
All
|
-0.89% |
AVXL |
Sell
All
|
11.03% |
EDIT |
Sell
All
|
-3.33% |
PACB |
Sell
All
|
-0.52% |
Assets Rebalanced
None
2024-05-20 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VCYT
Veracyte, Inc.
|
Buy |
9.92% |
1.69% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
11.12% |
14.04% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
9.6% |
-1.58% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
10.21% |
4.66% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
9.52% |
-2.1% |
2024-05-15 |
CYH
Community Health Systems, Inc.
|
Buy |
9.39% |
-3.48% |
2024-05-15 |
OMI
Owens & Minor, Inc.
|
Buy |
9.15% |
-5.86% |
2024-05-15 |
CUTR
Cutera, Inc.
|
Buy |
8.74% |
-10.12% |
2024-05-15 |
PODD
Insulet Corporation
|
Buy |
9.01% |
1.02% |
2024-05-17 |
The percentage of cash held in the portfolio is:
13.34%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
SGMO |
Sell
All
|
16.07% |
Assets Rebalanced
None
2024-05-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
10.44% |
8.93% |
2024-05-13 |
VCYT
Veracyte, Inc.
|
Buy |
9.98% |
4% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.82% |
12.78% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
9.9% |
3.15% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
10.89% |
13.47% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
9.37% |
-2.05% |
2024-05-15 |
CYH
Community Health Systems, Inc.
|
Buy |
9.49% |
-0.8% |
2024-05-15 |
OMI
Owens & Minor, Inc.
|
Buy |
9.24% |
-3.39% |
2024-05-15 |
CUTR
Cutera, Inc.
|
Buy |
9.1% |
-4.86% |
2024-05-15 |
PODD
Insulet Corporation
|
Buy |
8.77% |
0% |
2024-05-17 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MD |
Sell
All
|
-8.68% |
Assets Rebalanced
None
2024-05-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.72% |
1.79% |
2024-05-13 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
9.5% |
-0.59% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
9.78% |
2.31% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
10.33% |
8.02% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
9.51% |
-0.53% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
11.04% |
15.54% |
2024-05-14 |
BLFS
BioLife Solutions, Inc.
|
Buy |
9.53% |
0% |
2024-05-15 |
CYH
Community Health Systems, Inc.
|
Buy |
9.53% |
0% |
2024-05-15 |
OMI
Owens & Minor, Inc.
|
Buy |
9.53% |
0% |
2024-05-15 |
CUTR
Cutera, Inc.
|
Buy |
9.53% |
0% |
2024-05-15 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MOH |
Sell
All
|
0.04% |
Assets Rebalanced
None
2024-05-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MOH
Molina Healthcare, Inc.
|
Buy |
9.82% |
0.72% |
2024-05-08 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.63% |
-1.79% |
2024-05-13 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
9.82% |
0% |
2024-05-14 |
VCYT
Veracyte, Inc.
|
Buy |
9.82% |
0% |
2024-05-14 |
AVXL
Anavex Life Sciences Corp.
|
Buy |
9.82% |
0% |
2024-05-14 |
EDIT
Editas Medicine, Inc.
|
Buy |
9.82% |
0% |
2024-05-14 |
PACB
Pacific Biosciences of California, Inc.
|
Buy |
9.82% |
0% |
2024-05-14 |
The percentage of cash held in the portfolio is:
31.45%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ABUS |
Sell
All
|
3.21% |
Assets Rebalanced
None
2024-05-13 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ABUS
Arbutus Biopharma Corporation
|
Buy |
9.82% |
2.86% |
2024-05-07 |
MOH
Molina Healthcare, Inc.
|
Buy |
9.86% |
1.37% |
2024-05-08 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.79% |
0% |
2024-05-13 |
The percentage of cash held in the portfolio is:
70.52%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OMCL |
Sell
All
|
-0.03% |
NUTX |
Sell
All
|
-7.18% |
Assets Rebalanced
None
2024-05-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OMCL
Omnicell, Inc.
|
Buy |
10.77% |
-0.56% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
10.31% |
-4.82% |
2024-05-06 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
9.71% |
1.43% |
2024-05-07 |
MOH
Molina Healthcare, Inc.
|
Buy |
9.6% |
-1.55% |
2024-05-08 |
The percentage of cash held in the portfolio is:
59.61%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BLUE |
Sell
All
|
-3% |
PEN |
Sell
All
|
-4.03% |
INGN |
Sell
All
|
16.88% |
ACRS |
Sell
All
|
-3.17% |
IOVA |
Sell
All
|
7.12% |
SGMO |
Sell
All
|
-7.41% |
Assets Rebalanced
None
2024-05-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
INGN
Inogen, Inc.
|
Buy |
9.69% |
3.55% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.95% |
6.35% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
10.46% |
11.84% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.35% |
0% |
2024-05-02 |
OMCL
Omnicell, Inc.
|
Buy |
10.77% |
0.56% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
9.59% |
-10.41% |
2024-05-06 |
PEN
Penumbra, Inc.
|
Buy |
9.39% |
-0.77% |
2024-05-07 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
9.6% |
1.43% |
2024-05-07 |
BLUE
bluebird bio, Inc.
|
Buy |
9.56% |
1% |
2024-05-07 |
MOH
Molina Healthcare, Inc.
|
Buy |
9.64% |
0% |
2024-05-08 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SENS |
Sell
All
|
2.87% |
Assets Rebalanced
None
2024-05-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
SENS
Senseonics Holdings, Inc.
|
Buy |
9.68% |
3.49% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
9.52% |
1.99% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.71% |
3.97% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
10.37% |
11.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.17% |
-1.85% |
2024-05-02 |
OMCL
Omnicell, Inc.
|
Buy |
10.63% |
-0.5% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
10.58% |
-1% |
2024-05-06 |
PEN
Penumbra, Inc.
|
Buy |
9.45% |
0% |
2024-05-07 |
ABUS
Arbutus Biopharma Corporation
|
Buy |
9.45% |
0% |
2024-05-07 |
BLUE
bluebird bio, Inc.
|
Buy |
9.45% |
0% |
2024-05-07 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
IBRX |
Sell
All
|
-13.13% |
CDMO |
Sell
All
|
11.38% |
CARA |
Sell
All
|
4.5% |
Assets Rebalanced
None
2024-05-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IBRX
ImmunityBio, Inc.
|
Buy |
9.35% |
1.78% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
10.02% |
9.13% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.45% |
2.94% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
9.53% |
3.68% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
9.3% |
1.42% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.9% |
7.94% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
10% |
9.04% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.44% |
2.93% |
2024-05-02 |
OMCL
Omnicell, Inc.
|
Buy |
10.5% |
0% |
2024-05-06 |
NUTX
Nutex Health Inc.
|
Buy |
10.5% |
0% |
2024-05-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMMT |
Sell
All
|
13.73% |
PTCT |
Sell
All
|
15.54% |
Assets Rebalanced
None
2024-05-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
11.35% |
19.57% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
11.56% |
21.76% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
9.01% |
-5.01% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
9.63% |
1.46% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.53% |
0.4% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
9.02% |
-4.93% |
2024-05-01 |
INGN
Inogen, Inc.
|
Buy |
9.48% |
0% |
2024-05-02 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.48% |
0% |
2024-05-02 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
9.48% |
0% |
2024-05-02 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
9.48% |
0% |
2024-05-02 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-05-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
10.99% |
12.53% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
9.94% |
1.81% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
8.68% |
-11.12% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
9.85% |
0.93% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.71% |
-0.53% |
2024-04-30 |
SENS
Senseonics Holdings, Inc.
|
Buy |
9.77% |
0% |
2024-05-01 |
The percentage of cash held in the portfolio is:
41.06%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
10.89% |
12.5% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
9.73% |
0.52% |
2024-04-29 |
IBRX
ImmunityBio, Inc.
|
Buy |
9.67% |
0% |
2024-04-30 |
CDMO
Avid Bioservices, Inc.
|
Buy |
9.67% |
0% |
2024-04-30 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.67% |
0% |
2024-04-30 |
The percentage of cash held in the portfolio is:
50.37%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTCT
PTC Therapeutics, Inc.
|
Buy |
9.8% |
0% |
2024-04-29 |
SMMT
Summit Therapeutics Inc.
|
Buy |
9.8% |
0% |
2024-04-29 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-04-09 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
6.87% |
Assets Rebalanced
None
2024-04-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
10.12% |
3.82% |
2024-04-02 |
The percentage of cash held in the portfolio is:
89.88%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RVNC |
Sell
All
|
-10.37% |
LXRX |
Sell
All
|
-14.17% |
Assets Rebalanced
None
2024-04-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.46% |
-7.52% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
8.69% |
-15% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
10.04% |
3.05% |
2024-04-02 |
The percentage of cash held in the portfolio is:
71.82%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ANGO |
Sell
All
|
6.67% |
TNDM |
Sell
All
|
-2.95% |
KIDS |
Sell
All
|
-5.45% |
ACRS |
Sell
All
|
-0.79% |
Assets Rebalanced
None
2024-04-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
11.09% |
8.6% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.69% |
-5.1% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
9.41% |
-7.9% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.89% |
-3.17% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.36% |
-8.33% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.4% |
-7.92% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
10.02% |
3.05% |
2024-04-02 |
The percentage of cash held in the portfolio is:
31.12%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VCYT |
Sell
All
|
-5.57% |
Assets Rebalanced
None
2024-04-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
10.31% |
2.28% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.67% |
-4.11% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
9.81% |
-2.69% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
10.08% |
0% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
10.05% |
-0.37% |
2024-03-28 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.69% |
-3.86% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.58% |
-5% |
2024-03-29 |
OPK
OPKO Health, Inc.
|
Buy |
9.6% |
0% |
2024-04-02 |
The percentage of cash held in the portfolio is:
21.2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
OFIX |
Sell
All
|
-3.17% |
ATRI |
Sell
All
|
-11.81% |
Assets Rebalanced
None
2024-03-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
10.05% |
2.98% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.79% |
0.31% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
9.82% |
0.66% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.6% |
-1.59% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
9.96% |
2.03% |
2024-03-28 |
ATRI
Atrion Corporation
|
Buy |
9.76% |
0% |
2024-03-29 |
OFIX
Orthofix Medical Inc.
|
Buy |
9.76% |
0% |
2024-03-29 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.76% |
0% |
2024-03-29 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.76% |
0% |
2024-03-29 |
The percentage of cash held in the portfolio is:
11.76%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ANGO
AngioDynamics, Inc.
|
Buy |
9.8% |
0% |
2024-03-28 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.8% |
0% |
2024-03-28 |
KIDS
OrthoPediatrics Corp.
|
Buy |
9.8% |
0% |
2024-03-28 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.8% |
0% |
2024-03-28 |
VCYT
Veracyte, Inc.
|
Buy |
9.8% |
0% |
2024-03-28 |
The percentage of cash held in the portfolio is:
51%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-03-12 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ACRS |
Sell
All
|
3.2% |
QTRX |
Sell
All
|
-6.13% |
BHVN |
Sell
All
|
-1.79% |
RGNX |
Sell
All
|
6.98% |
APLS |
Sell
All
|
-6.1% |
Assets Rebalanced
None
2024-03-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
QTRX
Quanterix Corporation
|
Buy |
8.72% |
-5.45% |
2024-03-05 |
BHVN
Biohaven Ltd.
|
Buy |
9.48% |
2.8% |
2024-03-05 |
RGNX
REGENXBIO Inc.
|
Buy |
9.82% |
6.51% |
2024-03-05 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
10.4% |
12.8% |
2024-03-05 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
8.79% |
-4.64% |
2024-03-05 |
The percentage of cash held in the portfolio is:
52.79%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
THC |
Sell
All
|
4.66% |
MRSN |
Sell
All
|
-2.69% |
ENTA |
Sell
All
|
0.33% |
RDNT |
Sell
All
|
4.87% |
NTRA |
Sell
All
|
-0.39% |
Assets Rebalanced
None
2024-03-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
THC
Tenet Healthcare Corporation
|
Buy |
10.1% |
-0.63% |
2024-03-04 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
9.84% |
-3.2% |
2024-03-04 |
ENTA
Enanta Pharmaceuticals, Inc.
|
Buy |
10.36% |
1.95% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
10.73% |
5.61% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
10.25% |
0.89% |
2024-03-04 |
QTRX
Quanterix Corporation
|
Buy |
9.34% |
0% |
2024-03-05 |
BHVN
Biohaven Ltd.
|
Buy |
9.34% |
0% |
2024-03-05 |
RGNX
REGENXBIO Inc.
|
Buy |
9.34% |
0% |
2024-03-05 |
ACRS
Aclaris Therapeutics, Inc.
|
Buy |
9.34% |
0% |
2024-03-05 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.34% |
0% |
2024-03-05 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
MD |
Sell
All
|
-2.02% |
IONS |
Sell
All
|
-2.67% |
RVNC |
Sell
All
|
-14.99% |
Assets Rebalanced
None
2024-03-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MD
Pediatrix Medical Group, Inc.
|
Buy |
8.91% |
-1.35% |
2024-02-27 |
IONS
Ionis Pharmaceuticals, Inc.
|
Buy |
8.91% |
-1.39% |
2024-02-27 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
9.75% |
-2.24% |
2024-03-01 |
THC
Tenet Healthcare Corporation
|
Buy |
10.06% |
0% |
2024-03-04 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
10.06% |
0% |
2024-03-04 |
ENTA
Enanta Pharmaceuticals, Inc.
|
Buy |
10.06% |
0% |
2024-03-04 |
RDNT
RadNet, Inc.
|
Buy |
10.06% |
0% |
2024-03-04 |
NTRA
Natera, Inc.
|
Buy |
10.06% |
0% |
2024-03-04 |
The percentage of cash held in the portfolio is:
22.12%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PTGX |
Sell
All
|
12.89% |
CDNA |
Sell
All
|
45.22% |
Assets Rebalanced
None
2024-03-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.63% |
6.67% |
2024-02-26 |
CDNA
CareDx, Inc
|
Buy |
10.4% |
28.66% |
2024-02-26 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
9.41% |
2.92% |
2024-02-27 |
IONS
Ionis Pharmaceuticals, Inc.
|
Buy |
8.97% |
-1.93% |
2024-02-27 |
RVNC
Revance Therapeutics, Inc.
|
Buy |
10.1% |
0% |
2024-03-01 |
The percentage of cash held in the portfolio is:
52.49%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
-7.24% |
AMEH |
Sell
All
|
8.01% |
TNDM |
Sell
All
|
6.52% |
Assets Rebalanced
None
2024-02-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
7.35% |
4.96% |
2024-02-23 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
7.44% |
6.32% |
2024-02-23 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.65% |
6.85% |
2024-02-26 |
CDNA
CareDx, Inc
|
Buy |
9.52% |
17.53% |
2024-02-26 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
9.32% |
1.8% |
2024-02-27 |
IONS
Ionis Pharmaceuticals, Inc.
|
Buy |
9.24% |
0.95% |
2024-02-27 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.62% |
0% |
2024-02-29 |
The percentage of cash held in the portfolio is:
36.86%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
IOVA |
Sell
All
|
10.53% |
PTCT |
Sell
All
|
8.71% |
Assets Rebalanced
None
2024-02-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
8.02% |
10.78% |
2024-02-22 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
7.9% |
9.14% |
2024-02-22 |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
7.35% |
4.89% |
2024-02-23 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
7.66% |
9.36% |
2024-02-23 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
8.42% |
3.9% |
2024-02-26 |
CDNA
CareDx, Inc
|
Buy |
9.3% |
14.75% |
2024-02-26 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
9.29% |
1.35% |
2024-02-27 |
IONS
Ionis Pharmaceuticals, Inc.
|
Buy |
9.42% |
2.84% |
2024-02-27 |
The percentage of cash held in the portfolio is:
32.64%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
31.35% |
VKTX |
Sell
All
|
121.02% |
Assets Rebalanced
None
2024-02-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
8.77% |
5.26% |
2024-02-22 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
8.98% |
7.75% |
2024-02-22 |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
7.89% |
-2.11% |
2024-02-23 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.31% |
15.44% |
2024-02-23 |
RCM
R1 RCM Inc.
|
Buy |
11.67% |
25.14% |
2024-02-26 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.67% |
3.69% |
2024-02-26 |
CDNA
CareDx, Inc
|
Buy |
10.06% |
7.86% |
2024-02-26 |
MD
Pediatrix Medical Group, Inc.
|
Buy |
10.55% |
0% |
2024-02-27 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
10.55% |
0% |
2024-02-27 |
IONS
Ionis Pharmaceuticals, Inc.
|
Buy |
10.55% |
0% |
2024-02-27 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
KRYS |
Sell
All
|
41.02% |
Assets Rebalanced
None
2024-02-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
9.05% |
0% |
2024-02-22 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
9.44% |
4.36% |
2024-02-22 |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
8.57% |
-2.11% |
2024-02-23 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
10.2% |
16.52% |
2024-02-23 |
RCM
R1 RCM Inc.
|
Buy |
10.12% |
0% |
2024-02-26 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
10.12% |
0% |
2024-02-26 |
KRYS
Krystal Biotech, Inc.
|
Buy |
10.12% |
0% |
2024-02-26 |
CDNA
CareDx, Inc
|
Buy |
10.12% |
0% |
2024-02-26 |
The percentage of cash held in the portfolio is:
22.25%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
44.89% |
Assets Rebalanced
None
2024-02-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CARA
Cara Therapeutics, Inc.
|
Buy |
15.57% |
27.64% |
2024-02-19 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
9.48% |
1.08% |
2024-02-22 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
9.42% |
0.39% |
2024-02-22 |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
9.08% |
0% |
2024-02-23 |
TNDM
Tandem Diabetes Care, Inc.
|
Buy |
9.08% |
0% |
2024-02-23 |
The percentage of cash held in the portfolio is:
47.38%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
-0.27% |
INGN |
Sell
All
|
-7.68% |
NVAX |
Sell
All
|
13.49% |
MYGN |
Sell
All
|
-2.08% |
MTD |
Sell
All
|
0.01% |
SGMO |
Sell
All
|
-20.29% |
Assets Rebalanced
None
2024-02-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
8.76% |
-4.39% |
2024-02-16 |
INGN
Inogen, Inc.
|
Buy |
8.48% |
-7.49% |
2024-02-16 |
NVAX
Novavax, Inc.
|
Buy |
8.48% |
-7.44% |
2024-02-16 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.9% |
-2.88% |
2024-02-16 |
MTD
Mettler-Toledo International Inc.
|
Buy |
9.17% |
0.1% |
2024-02-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
11.36% |
-10.14% |
2024-02-19 |
CARA
Cara Therapeutics, Inc.
|
Buy |
13.65% |
7.99% |
2024-02-19 |
IOVA
Iovance Biotherapeutics, Inc.
|
Buy |
9.73% |
0% |
2024-02-22 |
PTCT
PTC Therapeutics, Inc.
|
Buy |
9.73% |
0% |
2024-02-22 |
The percentage of cash held in the portfolio is:
11.73%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
NUTX |
Sell
All
|
-3.28% |
BRKR |
Sell
All
|
2.34% |
CUTR |
Sell
All
|
-6.55% |
Assets Rebalanced
None
2024-02-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NUTX
Nutex Health Inc.
|
Buy |
9.71% |
0% |
2024-02-15 |
BRKR
Bruker Corporation
|
Buy |
9.93% |
2.21% |
2024-02-15 |
CUTR
Cutera, Inc.
|
Buy |
9.81% |
1.03% |
2024-02-15 |
RCM
R1 RCM Inc.
|
Buy |
8.7% |
-2.69% |
2024-02-16 |
INGN
Inogen, Inc.
|
Buy |
8.83% |
-1.18% |
2024-02-16 |
NVAX
Novavax, Inc.
|
Buy |
8.65% |
-3.26% |
2024-02-16 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.81% |
-1.44% |
2024-02-16 |
MTD
Mettler-Toledo International Inc.
|
Buy |
8.9% |
-0.44% |
2024-02-16 |
SGMO
Sangamo Therapeutics, Inc.
|
Buy |
12.33% |
0% |
2024-02-19 |
CARA
Cara Therapeutics, Inc.
|
Buy |
12.33% |
0% |
2024-02-19 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
FATE |
Sell
All
|
20.19% |
CHRS |
Sell
All
|
5.34% |
Assets Rebalanced
None
2024-02-16 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
FATE
Fate Therapeutics, Inc.
|
Buy |
12.3% |
12.56% |
2024-02-12 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
11.89% |
8.78% |
2024-02-12 |
NUTX
Nutex Health Inc.
|
Buy |
9.63% |
-0.82% |
2024-02-15 |
BRKR
Bruker Corporation
|
Buy |
9.71% |
0.06% |
2024-02-15 |
CUTR
Cutera, Inc.
|
Buy |
9.81% |
1.03% |
2024-02-15 |
RCM
R1 RCM Inc.
|
Buy |
8.93% |
0% |
2024-02-16 |
INGN
Inogen, Inc.
|
Buy |
8.93% |
0% |
2024-02-16 |
NVAX
Novavax, Inc.
|
Buy |
8.93% |
0% |
2024-02-16 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.93% |
0% |
2024-02-16 |
MTD
Mettler-Toledo International Inc.
|
Buy |
8.93% |
0% |
2024-02-16 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
AGEN |
Sell
All
|
-29.95% |
MRSN |
Sell
All
|
-9.22% |
Assets Rebalanced
None
2024-02-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
8.5% |
-10.4% |
2024-02-09 |
FATE
Fate Therapeutics, Inc.
|
Buy |
11.14% |
3.18% |
2024-02-12 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
11.21% |
3.82% |
2024-02-12 |
NUTX
Nutex Health Inc.
|
Buy |
9.59% |
0% |
2024-02-15 |
BRKR
Bruker Corporation
|
Buy |
9.59% |
0% |
2024-02-15 |
CUTR
Cutera, Inc.
|
Buy |
9.59% |
0% |
2024-02-15 |
AGEN
Agenus Inc.
|
Buy |
9.59% |
0% |
2024-02-15 |
The percentage of cash held in the portfolio is:
30.78%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
RGNX |
Sell
All
|
15.24% |
Assets Rebalanced
None
2024-02-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RGNX
REGENXBIO Inc.
|
Buy |
10.65% |
10.09% |
2024-02-08 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
8.7% |
-9.46% |
2024-02-09 |
FATE
Fate Therapeutics, Inc.
|
Buy |
11.11% |
1.59% |
2024-02-12 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
10.68% |
-2.29% |
2024-02-12 |
The percentage of cash held in the portfolio is:
58.86%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ARCT |
Sell
All
|
2.7% |
SAVA |
Sell
All
|
-6.26% |
SMTI |
Sell
All
|
-9.09% |
ATRI |
Sell
All
|
-2.04% |
AGEN |
Sell
All
|
8.57% |
CLDX |
Sell
All
|
-6.72% |
Assets Rebalanced
None
2024-02-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ATRI
Atrion Corporation
|
Buy |
10.15% |
8.91% |
2024-02-07 |
ARCT
Arcturus Therapeutics Holdings Inc.
|
Buy |
9.79% |
5.01% |
2024-02-07 |
AGEN
Agenus Inc.
|
Buy |
9.99% |
7.14% |
2024-02-07 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.53% |
2.2% |
2024-02-08 |
RGNX
REGENXBIO Inc.
|
Buy |
10.37% |
11.26% |
2024-02-08 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.38% |
0.61% |
2024-02-08 |
SAVA
Cassava Sciences, Inc.
|
Buy |
9.2% |
-1.34% |
2024-02-08 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
8.5% |
-8.27% |
2024-02-09 |
FATE
Fate Therapeutics, Inc.
|
Buy |
10.54% |
0% |
2024-02-12 |
CHRS
Coherus BioSciences, Inc.
|
Buy |
10.54% |
0% |
2024-02-12 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
LXRX |
Sell
All
|
12.21% |
NTLA |
Sell
All
|
11.63% |
Assets Rebalanced
None
2024-02-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
10.3% |
7.98% |
2024-02-05 |
NTLA
Intellia Therapeutics, Inc.
|
Buy |
10.36% |
8.62% |
2024-02-05 |
ATRI
Atrion Corporation
|
Buy |
9.97% |
5.75% |
2024-02-07 |
ARCT
Arcturus Therapeutics Holdings Inc.
|
Buy |
9.47% |
0.42% |
2024-02-07 |
AGEN
Agenus Inc.
|
Buy |
9.43% |
0% |
2024-02-07 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.82% |
4.06% |
2024-02-08 |
RGNX
REGENXBIO Inc.
|
Buy |
10.55% |
11.81% |
2024-02-08 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.36% |
-0.77% |
2024-02-08 |
SAVA
Cassava Sciences, Inc.
|
Buy |
9.38% |
-0.59% |
2024-02-08 |
MRSN
Mersana Therapeutics, Inc.
|
Buy |
9.37% |
0% |
2024-02-09 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.93% |
0.94% |
2024-02-05 |
NTLA
Intellia Therapeutics, Inc.
|
Buy |
10.14% |
3.08% |
2024-02-05 |
ATRI
Atrion Corporation
|
Buy |
10.27% |
5.59% |
2024-02-07 |
ARCT
Arcturus Therapeutics Holdings Inc.
|
Buy |
9.61% |
-1.19% |
2024-02-07 |
AGEN
Agenus Inc.
|
Buy |
9.44% |
-2.86% |
2024-02-07 |
SMTI
Sanara MedTech Inc.
|
Buy |
9.72% |
0% |
2024-02-08 |
RGNX
REGENXBIO Inc.
|
Buy |
9.72% |
0% |
2024-02-08 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
9.72% |
0% |
2024-02-08 |
SAVA
Cassava Sciences, Inc.
|
Buy |
9.72% |
0% |
2024-02-08 |
The percentage of cash held in the portfolio is:
11.72%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-07 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
10.17% |
3.76% |
2024-02-05 |
NTLA
Intellia Therapeutics, Inc.
|
Buy |
10.3% |
5.06% |
2024-02-05 |
ATRI
Atrion Corporation
|
Buy |
9.69% |
0% |
2024-02-07 |
ARCT
Arcturus Therapeutics Holdings Inc.
|
Buy |
9.69% |
0% |
2024-02-07 |
AGEN
Agenus Inc.
|
Buy |
9.69% |
0% |
2024-02-07 |
The percentage of cash held in the portfolio is:
50.46%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.57% |
-3.76% |
2024-02-05 |
NTLA
Intellia Therapeutics, Inc.
|
Buy |
9.76% |
-1.78% |
2024-02-05 |
The percentage of cash held in the portfolio is:
80.67%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PTGX |
Sell
All
|
-8.8% |
Assets Rebalanced
None
2024-02-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.17% |
-7.12% |
2024-02-02 |
LXRX
Lexicon Pharmaceuticals, Inc.
|
Buy |
9.87% |
0% |
2024-02-05 |
NTLA
Intellia Therapeutics, Inc.
|
Buy |
9.87% |
0% |
2024-02-05 |
The percentage of cash held in the portfolio is:
71.09%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-02-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.8% |
0% |
2024-02-02 |
The percentage of cash held in the portfolio is:
90.2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-11-22 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVCR |
Sell
All
|
-4.45% |
THC |
Sell
All
|
13.21% |
SGRY |
Sell
All
|
6.13% |
AMEH |
Sell
All
|
-3.9% |
KIDS |
Sell
All
|
7.82% |
QTRX |
Sell
All
|
4.1% |
VKTX |
Sell
All
|
1.61% |
MCRB |
Sell
All
|
-15.73% |
Assets Rebalanced
None
2023-11-21 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
NVCR
NovoCure Limited
|
Buy |
9.14% |
-4.77% |
2023-11-15 |
THC
Tenet Healthcare Corporation
|
Buy |
10.66% |
11.1% |
2023-11-15 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.21% |
6.39% |
2023-11-15 |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
9.58% |
-0.12% |
2023-11-15 |
KIDS
OrthoPediatrics Corp.
|
Buy |
10.21% |
6.45% |
2023-11-15 |
QTRX
Quanterix Corporation
|
Buy |
9.81% |
2.29% |
2023-11-15 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
10.11% |
5.37% |
2023-11-15 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
7.51% |
-21.77% |
2023-11-15 |
The percentage of cash held in the portfolio is:
22.77%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CBAY |
Sell
All
|
10.61% |
SENS |
Sell
All
|
6.13% |
Assets Rebalanced
None
2023-11-15 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CBAY
CymaBay Therapeutics, Inc.
|
Buy |
9.93% |
1.96% |
2023-11-14 |
SENS
Senseonics Holdings, Inc.
|
Buy |
10.15% |
4.22% |
2023-11-14 |
NVCR
NovoCure Limited
|
Buy |
9.74% |
0% |
2023-11-15 |
THC
Tenet Healthcare Corporation
|
Buy |
9.74% |
0% |
2023-11-15 |
SGRY
Surgery Partners, Inc.
|
Buy |
9.74% |
0% |
2023-11-15 |
AMEH
Apollo Medical Holdings, Inc.
|
Buy |
9.74% |
0% |
2023-11-15 |
KIDS
OrthoPediatrics Corp.
|
Buy |
9.74% |
0% |
2023-11-15 |
QTRX
Quanterix Corporation
|
Buy |
9.74% |
0% |
2023-11-15 |
VKTX
Viking Therapeutics, Inc.
|
Buy |
9.74% |
0% |
2023-11-15 |
MCRB
Seres Therapeutics, Inc.
|
Buy |
9.74% |
0% |
2023-11-15 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
- NVCR
- THC
- SGRY
- AMEH
- KIDS
- QTRX
- VKTX
- MCRB
Assets Removed
None
Assets Rebalanced
None
2023-11-14 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CBAY
CymaBay Therapeutics, Inc.
|
Buy |
9.8% |
0% |
2023-11-14 |
SENS
Senseonics Holdings, Inc.
|
Buy |
9.8% |
0% |
2023-11-14 |
The percentage of cash held in the portfolio is:
80.4%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-11-10 00:00:00
: Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is:
100%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OMI |
Sell
All
|
13.67% |
SGRY |
Sell
All
|
7.24% |
ISRG |
Sell
All
|
-1.98% |
RMD |
Sell
All
|
-4.45% |
THC |
Sell
All
|
-2.41% |
Assets Rebalanced
None
2023-11-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ISRG
Intuitive Surgical, Inc.
|
Buy |
9.36% |
0.01% |
2023-11-03 |
RMD
ResMed Inc.
|
Buy |
9.28% |
-0.88% |
2023-11-03 |
THC
Tenet Healthcare Corporation
|
Buy |
9.47% |
1.22% |
2023-11-03 |
SGRY
Surgery Partners, Inc.
|
Buy |
10.73% |
14.61% |
2023-11-03 |
OMI
Owens & Minor, Inc.
|
Buy |
11.15% |
19.15% |
2023-11-03 |
The percentage of cash held in the portfolio is:
50.01%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
BCRX |
Sell
All
|
-4.54% |
SMMT |
Sell
All
|
-6.41% |
EW |
Sell
All
|
3.78% |
EDIT |
Sell
All
|
21.74% |
VNDA |
Sell
All
|
-0.92% |
Assets Rebalanced
None
2023-11-03 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EW
Edwards Lifesciences Corporation
|
Buy |
9.98% |
2.66% |
2023-11-02 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
9.57% |
-1.57% |
2023-11-02 |
EDIT
Editas Medicine, Inc.
|
Buy |
9.91% |
1.88% |
2023-11-02 |
SMMT
Summit Therapeutics Inc.
|
Buy |
9.97% |
2.56% |
2023-11-02 |
VNDA
Vanda Pharmaceuticals Inc.
|
Buy |
9.95% |
2.29% |
2023-11-02 |
ISRG
Intuitive Surgical, Inc.
|
Buy |
9.72% |
0% |
2023-11-03 |
RMD
ResMed Inc.
|
Buy |
9.72% |
0% |
2023-11-03 |
THC
Tenet Healthcare Corporation
|
Buy |
9.72% |
0% |
2023-11-03 |
SGRY
Surgery Partners, Inc.
|
Buy |
9.72% |
0% |
2023-11-03 |
OMI
Owens & Minor, Inc.
|
Buy |
9.72% |
0% |
2023-11-03 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2023-11-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
EW
Edwards Lifesciences Corporation
|
Buy |
9.8% |
0% |
2023-11-02 |
BCRX
BioCryst Pharmaceuticals, Inc.
|
Buy |
9.8% |
0% |
2023-11-02 |
EDIT
Editas Medicine, Inc.
|
Buy |
9.8% |
0% |
2023-11-02 |
SMMT
Summit Therapeutics Inc.
|
Buy |
9.8% |
0% |
2023-11-02 |
VNDA
Vanda Pharmaceuticals Inc.
|
Buy |
9.8% |
0% |
2023-11-02 |
The percentage of cash held in the portfolio is:
51%
New Assets Added
Assets Removed
None
Assets Rebalanced
None